The development of an advanced lentiviral gene therapy for beta-thalassemia

Hongwei Liu, Yingying Wang, Rui Zhang, Lung-Ji Chang

Open source

DOI
10.1016/j.bbrc.2025.152963
Published
2025-12
Container
Biochemical and Biophysical Research Communications
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.bbrc.2025.152963,
  title = {The development of an advanced lentiviral gene therapy for beta-thalassemia},
  author = {Hongwei Liu and Yingying Wang and Rui Zhang and Lung-Ji Chang},
  year = {2025},
  journal = {Biochemical and Biophysical Research Communications},
  doi = {10.1016/j.bbrc.2025.152963},
  url = {https://doi.org/10.1016/j.bbrc.2025.152963}
}

RIS

TY  - JOUR
TI  - The development of an advanced lentiviral gene therapy for beta-thalassemia
AU  - Hongwei Liu
AU  - Yingying Wang
AU  - Rui Zhang
AU  - Lung-Ji Chang
PY  - 2025
JO  - Biochemical and Biophysical Research Communications
DO  - 10.1016/j.bbrc.2025.152963
UR  - https://doi.org/10.1016/j.bbrc.2025.152963
ER  - 

APA

Liu, H., Wang, Y., Zhang, R., & Chang, L. (2025). The development of an advanced lentiviral gene therapy for beta-thalassemia. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2025.152963

Source records